Followers | 20 |
Posts | 5932 |
Boards Moderated | 4 |
Alias Born | 05/23/2019 |
Tuesday, May 17, 2022 11:20:18 PM
UPDATED MAY 17, 2022
Tons of DILUTION DILUTION DILUTION coming to SHAREHOLDER Near YQU YQU Understand Have Mercy WQLF Ahooooooo
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=1688836
MARCH 31, 2022
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167440153
WQLF Says; Keep an Eye on this Link. MORE DILUTION DILUTION DILUTION to comeYQU Understand. Have Mercy WQLF Ahooooooo Imho
Dr. Joong J Fang Said; MINDMED has added another 10 MILLION shares to their Outstanding Shares since FEBRUARY 15, 2022. 10 Million shares ADDED in one month. 8,855,164 MILLION from February 15, 2022 to March 15, 2022 and 1,144,836 ADDED from MARCH 15, 2022 to MARCH 20, 2022.
Share Structure
Market Cap Market Cap
497,824,106
03/29/2022
Authorized Shares UNLIMITED
Authorized Shares
Unlimited
03/22/2022
Outstanding Shares
421,884,836
03/22/2022
Restricted
4,193,471
03/22/2022
Unrestricted
417,691,365
03/22/2022
Held at DTC
245,750,671
03/22/2022
FLOAT hasn’t been Updated since March 20, 2020.
Float
135,004,625
03/05/2020
Par Value
Not Available
https://www.otcmarkets.com/stock/MNMD/security
YAHOO Finance MARCH 15, 2022
Share Statistics
Avg Vol (3 month) 3 4.63M
Avg Vol (10 day) 3 2.95M
Shares Outstanding 5 420.74M
Implied Shares Outstanding 6 N/A
Float 8 411.82M
% Held by Insiders 1 16.52%
% Held by Institutions 1 12.71%
Shares Short (Mar 15, 2022) 4 26.72M
Short Ratio (Mar 15, 2022) 4 9.28
Short % of Float (Mar 15, 2022) 4 N/A
Short % of Shares Outstanding (Mar 15, 2022) 4 6.34%
Shares Short (prior month Feb 15, 2022) 4
Recent MNMD News
- MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York • Business Wire • 05/04/2024 12:00:00 PM
- MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update • Business Wire • 05/02/2024 11:00:00 AM
- MindMed to Present at Upcoming May Medical Conferences • Business Wire • 04/25/2024 11:00:00 AM
- MindMed to Present at Upcoming April Medical Conferences • Business Wire • 04/02/2024 11:00:00 AM
- MindMed Announces Voluntary Delisting from Cboe Canada • Business Wire • 04/01/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 12:32:03 PM
- MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference • Business Wire • 03/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:19:43 PM
- Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement • Business Wire • 03/07/2024 12:13:00 PM
- Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)] • Edgar (US Regulatory) • 03/07/2024 12:09:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:56:00 AM
- MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder • Business Wire • 03/07/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 06:56:37 PM
- MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120 • Business Wire • 03/01/2024 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:45:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 12:20:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 12:15:11 PM
- MindMed Reports 2023 Financial Results and Business Updates • Business Wire • 02/28/2024 12:05:00 PM
- MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update • Business Wire • 02/22/2024 12:00:00 PM
- MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference • Business Wire • 02/07/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:00:24 PM
- MindMed Announces Business Update and Anticipated Milestones for 2024 • Business Wire • 01/08/2024 12:45:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM